These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2802968)

  • 1. An experimental model comparing the antineoplastic and the immunosuppressive effects of some cytostatics.
    Ghyka G; Haraga L
    Arch Roum Pathol Exp Microbiol; 1989; 48(1):33-45. PubMed ID: 2802968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hamster apigmented melanoma as a model for screening of potential antineoplastic drugs.
    Stoychkov J; Dämianova M
    Neoplasma; 1977; 24():161-4. PubMed ID: 865646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
    Köpf-Maier P
    In Vivo; 1998; 12(3):275-88. PubMed ID: 9706471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression by cytostatic drugs?
    Ulrichs K; Yu MY; Duncker D; Müller-Ruchholtz W
    Behring Inst Mitt; 1984 May; (74):239-49. PubMed ID: 6332617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental antitumor activity of Navelbine.
    Cros S; Wright M; Morimoto M; Lataste H; Couzinier JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):15-20. PubMed ID: 2711203
    [No Abstract]   [Full Text] [Related]  

  • 8. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experimental study of the antitumor properties of olipifat].
    Filov VA; Reztsova VV; Kil'maeva NE; Petukhov DV; Pinchuk BT
    Vopr Onkol; 2000; 46(3):332-6. PubMed ID: 10976281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2.
    Fu LW; He LR; Liang YJ; Chen LM; Xiong HY; Yang XP; Pan QC
    Yao Xue Xue Bao; 2003 Aug; 38(8):565-70. PubMed ID: 14628443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability].
    Frankfurt OS
    Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
    Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
    Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical prediction of experimental chemotherapy of gynecological tumor xenografts.
    Kleine W
    Behring Inst Mitt; 1984 May; (74):337-42. PubMed ID: 6477361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of interferon on the toxic effect and antitumor activity of vinblastine in the combined therapy of metastatic Lewis carcinoma].
    Vorontsova AL; Kudriavets IuI; Fadeev VA
    Eksp Onkol; 1984; 6(6):54-7. PubMed ID: 6084588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanisms of the disordered regulation of hematopoiesis in the late periods after the administration of cytostatic preparations].
    Novitskiĭ VV; Zapuskalova OB; Bogdashin IV; Gol'dberg ED
    Patol Fiziol Eksp Ter; 1991; (3):12-4. PubMed ID: 1923603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
    Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of lethal and cytostatic effects of alkylnitrosoureas on the cells of experimental tumors.
    Emanuel NM; Ostrovskaya LA; Krutova TV; Konradov AA
    Neoplasma; 1984; 31(5):529-38. PubMed ID: 6504211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
    Mattern J; Wayss K; Volm M
    J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.